Thermosensitive injectable graphene oxide/chitosan-based nanocomposite hydrogels for controlling the in vivo release of bupivacaine hydrochloride.

MLA

Al homsi, Reem, et al. “Thermosensitive Injectable Graphene Oxide/Chitosan-Based Nanocomposite Hydrogels for Controlling the in Vivo Release of Bupivacaine Hydrochloride.” International Journal of Pharmaceutics, vol. 621, June 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2022.121786.

APA

Al homsi, R., Eltahir, S., Jagal, J., Ali Abdelkareem, M., Ghoneim, M. M., Rawas-Qalaji, M. M., Greish, K., & Haider, M. (2022). Thermosensitive injectable graphene oxide/chitosan-based nanocomposite hydrogels for controlling the in vivo release of bupivacaine hydrochloride. International Journal of Pharmaceutics, 621, N.PAG. https://doi.org/10.1016/j.ijpharm.2022.121786

Chicago

Al homsi, Reem, Safaa Eltahir, Jayalakshmi Jagal, Mohammad Ali Abdelkareem, Mohamed M. Ghoneim, Mutasem M. Rawas-Qalaji, Khaled Greish, and Mohamed Haider. 2022. “Thermosensitive Injectable Graphene Oxide/Chitosan-Based Nanocomposite Hydrogels for Controlling the in Vivo Release of Bupivacaine Hydrochloride.” International Journal of Pharmaceutics 621 (June): N.PAG. doi:10.1016/j.ijpharm.2022.121786.